The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Norway.
Acta Orthop. 2011 Oct;82(5):530-7. doi: 10.3109/17453674.2011.623572.
Controversies still exist regarding the best surgical procedure in the treatment of periprosthetic infection after total hip arthroplasty (THA). Based on data in the Norwegian Arthroplasty Register (NAR), we have compared the risk of re-revision after 4 different surgical procedures: 2-stage with exchange of the whole prosthesis, 1-stage with exchange of the whole prosthesis, major partial 1-stage with exchange of stem or cup, and minor partial 1-stage with exchange of femoral head and/or acetabular liner.
Between 1987 and 2009, 124,759 primary THAs were reported to the NAR, of which 906 (0.7%) were revised due to infection. Included in this study were the 784 revisions that had been performed by 1 of the 4 different surgical procedures. Cox-estimated survival and relative revision risks are presented with adjustment for differences among groups regarding gender, type of fixation, type of prosthesis, and age at revision.
2-stage procedures were used in 283 revisions (36%), 1-stage in 192 revisions (25%), major partial in 129 revisions (17%), and minor partial in 180 revisions (23%). 2-year Kaplan-Meier survival for all revisions was 83%; it was 92% for those re-revised by 2-stage exchange procedure, 88% for those re-revised by 1-stage exchange procedure, 66% for those re-revised by major partial exchange procedure, and it was 76% for those re-revised by minor partial exchange. Compared to the 2-stage procedure and with any reason for revision as endpoint (180 re-revisions), the risk of re-revision increased 1.4 times for 1-stage (p = 0.2), 4.1 times for major partial exchange (p < 0.001), and 1.5 times for minor partial exchange (p = 0.1). With infection as the endpoint (108 re-revisions), the risk of re-revision increased 2.0 times for 1-stage exchange (p = 0.04), 6.0 times for major partial exchange (p < 0.001), and 2.3 times for minor partial exchange (p = 0.02). Similar results were found when the analyses were restricted to the period 2002-2009.
In the Norwegian Arthroplasty Register, the survival after revision of infected primary THA with 2-stage implant exchange was slightly superior to that for 1-stage exchange of the whole prosthesis. This result is noteworthy, since 2-stage procedures are often used with the most severe infections. However, debridement with exchange of head and/or liner but with retention of the fixed implant (minor revision) meant that there was a 76% chance of not being re-revised within 2 years.
全髋关节置换术后假体周围感染的最佳手术方法仍存在争议。基于挪威关节置换登记处(NAR)的数据,我们比较了 4 种不同手术方法后的再次翻修风险:2 期整个假体置换术、1 期整个假体置换术、主要部分 1 期置换术(仅更换柄或杯)和次要部分 1 期置换术(仅更换股骨头和/或髋臼衬垫)。
1987 年至 2009 年间,NAR 报告了 124759 例初次全髋关节置换术,其中 906 例(0.7%)因感染而翻修。本研究纳入了其中 784 例采用 4 种不同手术方法之一进行的翻修。使用 Cox 估计的生存率和相对翻修风险,并针对性别、固定类型、假体类型和翻修时的年龄等组间差异进行了调整。
2 期手术占 283 例(36%),1 期手术占 192 例(25%),主要部分手术占 129 例(17%),次要部分手术占 180 例(23%)。所有翻修术的 2 年 Kaplan-Meier 生存率为 83%;2 期置换术再次翻修的生存率为 92%,1 期置换术再次翻修的生存率为 88%,主要部分置换术再次翻修的生存率为 66%,次要部分置换术再次翻修的生存率为 76%。与 2 期手术相比,任何原因的翻修为终点(180 例再次翻修),1 期手术(p=0.2)的再次翻修风险增加 1.4 倍,主要部分置换术(p<0.001)的再次翻修风险增加 4.1 倍,次要部分置换术(p=0.1)的再次翻修风险增加 1.5 倍。以感染为终点(108 例再次翻修),1 期置换术(p=0.04)的再次翻修风险增加 2.0 倍,主要部分置换术(p<0.001)的再次翻修风险增加 6.0 倍,次要部分置换术(p=0.02)的再次翻修风险增加 2.3 倍。当分析仅限于 2002-2009 年期间时,得到了类似的结果。
在挪威关节置换登记处,2 期植入物置换术治疗感染性初次全髋关节置换术后的生存率略优于 1 期整个假体置换术。这一结果值得注意,因为 2 期手术通常用于治疗最严重的感染。然而,保留固定植入物(仅进行股骨头和/或衬垫置换术)进行清创术意味着,在 2 年内再次翻修的可能性为 76%。